Skip to main content
. 2022 Dec 15;108(5):1232–1243. doi: 10.3324/haematol.2022.281562

Table 3.

Differences in regulatory requirements for originator compounds, generics, and biosimilars.

graphic file with name 1081232.tab3.jpg